← Back to Patent Explorer
US5336194A Expired / Lapsed US ⏱️ 0.0 years remaining

Implantable apparatus

Assignee: Fresenius Hemocare GmbH
•
Filing: 1993-07-27
•
Granted: 1994-08-09
•
Expires: 2013-07-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Implantable infusion apparatus comprising a chamber sealed by a septum and having an outlet aperture leading therefrom, to which a catheter tube is connected. A wire anchored in the chamber base projects into the catheter lumen, forming a ring slot whose diameter is smaller than the average size of a punched out particle. The wire thus serves as a particle retention means.

Inventors

  • 👤 Hans-Dietrich Polaschegg
  • 👤 Bernd Steinbach

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 05:03
CPC Classifications
A; A61; A61M; A61M39/00; A61M39/02; A61M39/0208; A61M5/00; A61M5/14; A61M5/165; A61M2039/0211; A61M2039/0241

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 109 words
Implantable apparatus for dosed administration of liquid medicines in the human body, with a housing having at least one chamber for storing a liquid medicine defined by at least one wall, an inlet aperture in the housing sealed by a perfortable spectum and flow-connected to said chamber, and an outlet aperture in the housing connected to a catheter tube with a lumen and with particle retention means disposed in the area of the outlet aperture, wherein said particle retention means comprises a wire anchored in the chamber wall and projecting into said outlet aperture to form a ring slot in order to restrict the diameter of said outlet aperture.
Claim 2
Dependent Claim 109 words
Implantable apparatus for dosed administration of liquid medicines in the human body, with a housing having at least one chamber for storing a liquid medicine defined by at least one wall, an inlet aperture in the housing sealed by a perfortable spectum and flow-connected to said chamber, and an outlet aperture in the housing connected to a catheter tube with a lumen and with particle retention means disposed in the area of the outlet aperture, wherein said particle retention means comprises a wire anchored in the chamber wall and projecting into said outlet aperture to form a ring slot in order to restrict the diameter of said outlet aperture.
Claim 3
Dependent Claim 20 words
Apparatus according to claim 1 wherein the diameter of the ring is smaller than the average diameter of a particle.
Claim 4
Dependent Claim 110 words
Implantable apparatus for dosed administration of liquid medicines in the human body, with a housing having at least one chamber for storing a liquid medicine defined by at least one wall, an inlet aperture in the housing sealed by a perfortable spectum and flow connected to said chamber, and an outlet aperture in the housing connected to a catheter tube with a lumen and with particle retention means disposed in the area of the outlet aperture, wherein said particle retention means comprises a capillary anchored in the chamber wall and projecting into said outlet aperture to form a ring slot in order to restrict the diameter of said outlet aperture.
Claim 5
Dependent Claim 110 words
Implantable apparatus for dosed administration of liquid medicines in the human body, with a housing having at least one chamber for storing a liquid medicine defined by at least one wall, an inlet aperture in the housing sealed by a perfortable spectum and flow connected to said chamber, and an outlet aperture in the housing connected to a catheter tube with a lumen and with particle retention means disposed in the area of the outlet aperture, wherein said particle retention means comprises a capillary anchored in the chamber wall and projecting into said outlet aperture to form a ring slot in order to restrict the diameter of said outlet aperture.
Claim 6
Dependent Claim 21 words
Apparatus according to claim 3 wherein the diameter of the ring slot is smaller than the average diameter of a particle.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-08-08 1998-02-07 1998-08-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-08-08 2002-02-07 2002-08-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-08-08 2006-02-07 2006-08-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag